You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
|
---|---|
Published in |
New England Journal of Medicine, April 2019
|
DOI | 10.1056/nejmoa1802264 |
Pubmed ID | |
Authors |
Chang-Yi Wang, Wing-Wai Wong, Hung-Chin Tsai, Yen-Hsu Chen, Be-Sheng Kuo, Shugene Lynn, Jana Blazkova, Katherine E Clarridge, Hsiao-Wen Su, Chia-Ying Lin, Fan-Chen Tseng, Annie Lai, Fu-Hung Yang, Chen-Han Lin, William Tseng, Hsiao-Yi Lin, Connie L Finstad, Flossie Wong-Staal, Carl V Hanson, Tae-Wook Chun, Mei-June Liao |
X Demographics
The data shown below were collected from the profiles of 69 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 14 | 20% |
Mexico | 7 | 10% |
Venezuela, Bolivarian Republic of | 6 | 9% |
Spain | 2 | 3% |
Brazil | 1 | 1% |
Philippines | 1 | 1% |
France | 1 | 1% |
Nigeria | 1 | 1% |
Japan | 1 | 1% |
Other | 5 | 7% |
Unknown | 30 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 47 | 68% |
Practitioners (doctors, other healthcare professionals) | 13 | 19% |
Scientists | 7 | 10% |
Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 106 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 15% |
Student > Bachelor | 16 | 15% |
Other | 10 | 9% |
Student > Ph. D. Student | 9 | 8% |
Student > Master | 7 | 7% |
Other | 21 | 20% |
Unknown | 27 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 23 | 22% |
Biochemistry, Genetics and Molecular Biology | 14 | 13% |
Immunology and Microbiology | 11 | 10% |
Agricultural and Biological Sciences | 8 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Other | 10 | 9% |
Unknown | 35 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 304. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2020.
All research outputs
#115,403
of 25,713,737 outputs
Outputs from New England Journal of Medicine
#2,767
of 32,648 outputs
Outputs of similar age
#2,254
of 364,923 outputs
Outputs of similar age from New England Journal of Medicine
#62
of 273 outputs
Altmetric has tracked 25,713,737 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,648 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,923 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.